High-Quality Pharmaceutical Grade Benserazide for Parkinson's Disease - Trustworthy and Reliable
ProcurenetShort description
High-Quality Benserazide – Pharmaceutical Grade is a superior compound, commonly used in the medical industry for the treatment of Parkinson’s disease. As a dopa decarboxylase inhibitor, it enhances the efficacy of levodopa by inhibiting its degradation. This product is manufactured adhering to the highest standards of purity and quality.
- Active Ingredient: Benserazide
- Chemical Formula: C10H15N3O5
- Molecular Weight: 257.24 g/mol
- Usage: Efficiently paired with levodopa for Parkinson’s disease management
Available in various packaging sizes to suit different business needs.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
High-Quality Benserazide - Pharmaceutical Grade for Parkinson's Disease Treatment
Benserazide is a high-quality pharmaceutical-grade compound renowned for its significant role in managing Parkinson's disease. A proven peripheral decarboxylase inhibitor, this product inhibits the enzyme that breaks down Levodopa, improving the potency and duration of Levodopa's effects.
Key Features and Specifications
- CAS Number: 14919-77-8 ensures authenticity and regulatory compliance.
- Molecular Formula: C10H15N3O5 for validating the right compound.
- Molecular Weight: 257.25 g/mol.
- Grade: Pharmaceutical grade guarantees manufacturing and purity of the compound.
- Use: Primarily used with Levodopa in managing Parkinson's disease.
- Exceptional Safety: Adheres to all international safety standards and quality benchmarks.
- Packaging: Customizable as per customer's need, ensuring the compound's integrity and stability.
About Benserazide
With a CAS Number of 14919-77-8, Benserazide, also known by its IUPAC name 2-amino-3-hydroxy-N-(2,3,4-trihydroxybenzyl)propanamide, have demonstrated immense therapeutic significance. Renowned for its exceptional quality, this compound features broad-range pharmacological applications bolstering its appeal within the scientific and health sectors.
As a peripheral decarboxylase inhibitor, Benserazide plays a pivotal role in slowing the breakdown of Levodopa, thus prolonging the latter's efffectiveness, making it invaluable in Parkinson's disease management. However, it's critical to note that like any medical compound, Benserazide has potential side effects and contraindications, hence, it needs administration under a competent healthcare provider's supervision.
